PTP
AGN

Platform Technology Partners’s Allergan plc AGN Stock Holding History

Platform Technology Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,322
Closed -$234K – 210
2020
Q1 		$234K Buy
1,322
+76
+6% +$14.3K 0.21% 130
2019
Q4 		$238K Buy
+1,246
New +$225K 0.18% 145

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Platform Technology Partners's AGN Position: Q2 2020 in Review

Platform Technology Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,322 shares — an estimated $234K sold.

Platform Technology Partners first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $238K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Platform Technology Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Platform Technology Partners sold 1,322 Allergan plc shares in Q2 2020, an estimated $234K.
  • Platform Technology Partners first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Platform Technology Partners's Allergan plc position peaked at $238K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Platform Technology Partners's 13F filing for Q2 2020, filed 30 Nov 2020.